Diagnos Laboratorium Utama Tbk. vs Saptausaha Gemilangindah Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Saptausaha Gemilangindah Tbk. trades at Rp31 (market cap 265.11B, 3.14M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Saptausaha Gemilangindah Tbk. is more actively traded (3.14M versus 27.5K). Which is the better fit depends on your goals.
| DGNS | SAGE | |
|---|---|---|
Market Cap | 308B | 265.11B |
Volume | 27.5K | 3.14M |
Lot | 275 | 31.36K |
Turnover | 6.23M | 97.21M |
Average Price | 226.59 | 31 |
Value | 6.23M | 97.21M |
Indicative Equilibrium Price | 230 | 31 |
Indicative Equilibrium Volume | 110 | 20.23K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Saptausaha Gemilangindah Tbk (the Company) was established on July 29, 1992 based onNotarial Deed No. 63 of Sulaimansjah, S.H., notary in Jakarta. The Company started its commercial operations on 2017.
Read more on SAGE →